Clinical Trials Directory

Trials / Terminated

TerminatedNCT03248596

Interest in Evaluating Primary Hemostasis in Patients With Veno-venous Extracorporeal Membrane Oxygenation (ECMO)

Status
Terminated
Phase
Study type
Observational
Enrollment
5 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is a better understanding of hemorrhagic events causes in patients with ECMO, prevent them and decrease the number of transfusion.

Detailed description

The most frequent complication during ECMO is hemorrhage especially as a curative anticoagulant treatment is necessary. The primary hemostasis is also affected with a von Willebrand disease and thrombopathy, well known but not studied by recent tests.The identification of primary haemostasis deficits with these tools would allow to supply them and decrease the morbi-mortality related to the transfusion.

Conditions

Timeline

Start date
2016-02-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2017-08-14
Last updated
2017-11-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03248596. Inclusion in this directory is not an endorsement.